FIGURE 7.

Antifibrotic role of curcumin (CUR) in urinary system fibrosis. CUR protects against tubulointerstitial fibrosis through multiple interconnected pathways: (1) inhibiting epithelial–mesenchymal transition (EMT), (2) blocking transforming growth factor β (TGF-β)/Smad and MAPK signaling, (3) activating peroxisome proliferator-activated receptor-γ (PPARγ) and suppressing inflammation, (4) improving mitochondrial function and autophagy, (5) suppressing PI3K/AKT/mTOR and hypoxia-inducible factor 1α (HIF-1α)/vascular endothelial growth factor (VEGF) axes. These coordinated effects attenuate extracellular matrix (ECM) deposition, preserve the tubular structure, and promote DKD progression.